Company Filing History:
Years Active: 2019
Title: Innovations of Alberto Purwada in Immune Organoid Technology.
Introduction
Alberto Purwada is an innovative inventor based in Ithaca, NY (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of immune organoids. His work focuses on creating advanced models that can mimic human immune responses, which are crucial for research and therapeutic applications.
Latest Patents
Alberto Purwada holds a patent for "Ex vivo engineered immune organoids for controlled germinal center reactions." This patent describes compositions and methods related to ex vivo organoids that contain B cells and stromal cells within a three-dimensional material, including a hydrogel. The hydrogel is notable for being formed without exposure to ultraviolet light from an electronic ultraviolet light source. It incorporates silicate nanoparticles (SiNPs) that are ionically bonded to a polyampholytic gelatin. The organoids are designed to maintain their structure at temperatures of at least 37 degrees Celsius without liquefying. They exhibit mechanical properties similar to certain lymphoid tissues and can include a germinal center. The patent also outlines methods for creating these organoids and high-throughput screening approaches for testing various agents.
Career Highlights
Alberto Purwada is affiliated with Cornell University, where he conducts his research and development work. His innovative approach to immune organoid technology has positioned him as a key figure in the field. He has successfully translated complex biological concepts into practical applications that can enhance our understanding of immune responses.
Collaborations
Alberto collaborates with Ankur Singh, a fellow researcher, to further advance the field of immune organoid technology. Their combined expertise contributes to the development of novel methodologies and applications in biomedical research.
Conclusion
Alberto Purwada's work in the field of immune organoids represents a significant advancement in biomedical engineering. His innovative patent and collaboration efforts are paving the way for future research and therapeutic applications.